Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/KS/Overland Park
Updated September 2026 from ClinicalTrials.gov

Paid Clinical Trials in Overland Park, KS

Studies commonly pay $75 to $4,500 per completed study

1,030 clinical trials are currently recruiting participants within 30 miles of Overland Park. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

1,030studies recruiting
9+research centers nearby
6condition categories
Live from the NIH registry

Studies recruiting near Overland Park right now

Top 25 of 1,030 recruiting studies, sorted by proximity — each links to its official registry page

One-Time DNA Study for Vasculitis

Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Giant Cell Arteritis N/A Observational 1,000 participants sought
University of Kansas Medical Center — Kansas City, Kansas (16.0 mi) · Sponsor: University of Pennsylvania
See eligibility & contact on ClinicalTrials.gov (NCT01241305)

Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A

Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia Phase 1 Interventional 40 participants sought
Children's Mercy Hospital — Kansas City, Missouri (15.8 mi) · Sponsor: Bleeding and Clotting Disorders Institute Peoria, Illinois
See eligibility & contact on ClinicalTrials.gov (NCT05500807)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
Children's Mercy Hospitals and Clinics — Kansas City, Missouri (15.8 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06124157)

Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy

Chronic Graft-versus-host Disease (cGVHD) Phase 2 Interventional 120 participants sought
University of Kansas Cancer Center — Kansas City, Kansas (16.0 mi) · Sponsor: H. Lee Moffitt Cancer Center and Research Institute
See eligibility & contact on ClinicalTrials.gov (NCT06660355)

Nutrition OUtReach In Systems of Healthcare

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, Autologous Haemopoietic Stem Cell Transplant N/A Interventional 210 participants sought
University of Kansas Cancer Center — Fairway, Kansas (9.8 mi) · Sponsor: University of Kansas Medical Center
See eligibility & contact on ClinicalTrials.gov (NCT06802406)

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

PIK3CA Mutation, HER2- Negative Breast Cancer Phase 3 Interventional 540 participants sought
University of Kansas Cancer Center — Westwood, Kansas (11.3 mi) · Sponsor: Relay Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06982521)

A Study of Buntanetap in Participants With PD

Parkinson's Disease (PD), Deep Brain Stimulation Phase 2, Phase 3 Interventional 500 participants sought
University of Kansas Medical Center (KUMC) - School of Medicine - Parkinson's Disease and Movement D — Kansas City, Kansas (16.0 mi) · Sponsor: Annovis Bio Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07284784)

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
University of Kansas Cancer Center-Overland Park — Overland Park, Kansas (6.6 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.

Spasticity Phase 1, Phase 2 Interventional 240 participants sought
Kansas Institute of Research — Overland Park, Kansas (6.6 mi) · Sponsor: Ipsen
See eligibility & contact on ClinicalTrials.gov (NCT04752774)

A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1)

Limb Girdle Muscular Dystrophy, Limb-Girdle Muscular Dystrophy Type 2 Phase 1, Phase 2 Interventional 10 participants sought
University of Kansas Medical Center — Kansas City, Kansas (16.0 mi) · Sponsor: AskBio Inc
See eligibility & contact on ClinicalTrials.gov (NCT05230459)

A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)

Amyloid Plaque, Beta-Amyloid Phase 1, Phase 2 Interventional 304 participants sought
University of Kansas Medical Center Research Institute — Fairway, Kansas (9.8 mi) · Sponsor: AC Immune SA
See eligibility & contact on ClinicalTrials.gov (NCT05462106)

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

Solid Tumor, Adult, Metastatic Breast Cancer Phase 1 Interventional 392 participants sought
St. Lukes Hospital of Kansas City — Kansas City, Missouri (15.8 mi) · Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
See eligibility & contact on ClinicalTrials.gov (NCT06625775)

A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)

Colo-rectal Cancer Phase 2 Interventional 79 participants sought
University of Kansas Cancer Center — Kansas City, Kansas (16.0 mi) · Sponsor: NSABP Foundation Inc
See eligibility & contact on ClinicalTrials.gov (NCT07058012)

Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor

HPV-unrelated Head and Neck Squamous Cell Carcinoma Phase 3 Interventional 81 participants sought
Saint Luke's Hospital — Kansas City, Missouri (15.8 mi) · Sponsor: Washington University School of Medicine
See eligibility & contact on ClinicalTrials.gov (NCT04966481)

A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care

Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) N/A Observational 30 participants sought
University of Kansas Medical Center Research Institute, Inc. — Kansas City, Kansas (16.0 mi) · Sponsor: Takeda
See eligibility & contact on ClinicalTrials.gov (NCT06538064)

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

Systemic Lupus Erythematosus Phase 3 Interventional 450 participants sought
Sl0044 50682 — Kansas City, Missouri (15.8 mi) · Sponsor: UCB Biopharma SRL
See eligibility & contact on ClinicalTrials.gov (NCT06617325)

A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia

Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis Phase 2 Interventional 168 participants sought
Johnson County Clinical Trials — Kansas City, Missouri (15.8 mi) · Sponsor: R1 Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT06712654)

A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease

Chronic Kidney Disease Phase 2 Interventional 465 participants sought
Clinical Research Consultants — Kansas City, Missouri (15.8 mi) · Sponsor: Novo Nordisk A/S
See eligibility & contact on ClinicalTrials.gov (NCT06717698)

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Phase 2 Interventional 40 participants sought
Ohio State University-Telemedicine — Kansas City, Kansas (16.0 mi) · Sponsor: Sameek Roychowdhury
See eligibility & contact on ClinicalTrials.gov (NCT06906562)

A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction

Left Ventricular Systolic Dysfunction, Heart Failure (Pediatric) Phase 3 Interventional 117 participants sought
Children's Mercy Hospital Kansas City - Cardiology — Kansas City, Missouri (15.8 mi) · Sponsor: Bayer
See eligibility & contact on ClinicalTrials.gov (NCT07192952)

Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis

Liver Fibrosis, Hepatic Cirrhosis Phase 2 Interventional 104 participants sought
Research Site — Kansas City, Missouri (15.8 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT07610837)

A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies

Myelodysplastic Syndrome, Acute Myeloid Leukemia Phase 1 Interventional 178 participants sought
The University of Kansas Cancer Center - Overland Park — Overland Park, Kansas (6.6 mi) · Sponsor: Seagen, a wholly owned subsidiary of Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT04227847)
Actively enrolling

Studies you may be able to join near Overland Park

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Overland Park

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

DelRicht Research of Overland Park Clinical Trials | Dr. Jonathan Jacobs

★ 4.9
5701 W 119th St #242, Overland Park, KS 66209
(913) 391-7188
"Do not go there. Showed up for the appointment after receiving a call to confirm the day before. Lady walked out and told us that the study was fille…"
— Cliff Pitts, 1★

Johnson County Clin Trials - JCCT

★ 4.7
16400 College Blvd, Lenexa, KS 66219
(913) 825-4400
"Always on time and professional. I'm realy for another trial, if they'll have me."
— Phyllis Cronbaugh, 5★

ICON - Lenexa

★ 3.3
9755 Ridge Dr, Lenexa, KS 66219
(913) 410-2000
"Boy they have really gone downhill!!! I went in for a cholesterol study. They wanted people with high cholesterol and not on medication. I even told …"
— Cathie Sims, 1★

Dr. Vince Clinical Research

★ 4.5
7401 W 91st St, Overland Park, KS 66212
(913) 333-3000
"Very good experience!!! Staff, roommates, doctors all of them lovely 🥰🥳🫶👍 thank you Kat for an amazing first time in there 😊🤩 see you soon!!!"
— Sara H, 5★

Kansas City Research Institute

★ 5.0
6667 Holmes Rd Ste 129, Kansas City, MO 64131
(816) 759-5274
"Professional, quick & efficient"
— Michael Fleschman, 5★

Altasciences KC

★ 3.1
10103 Metcalf Ave, Overland Park, KS 66212
(913) 213-2970
"I'd rather not say as to the experience that i had."
— linda lindsey, 3★

Analab Clinical Research, Inc.

★ 5.0
15335 W 95th St, Lenexa, KS 66219
(913) 221-0421

Neuroscience Research Center, LLC

10995 Quivira Rd, Overland Park, KS 66210
(913) 825-2314

University of Kansas Medical Center Research Institute

★ 5.0
3901 Rainbow Blvd, Kansas City, KS 66160
(913) 588-1261
"The doctors are very nice and helpful."
— Everian Williams, 5★

Clinical trials in Overland Park: what's recruiting

The Overland Park area currently has 1,030 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Overland Park, the most active research areas are:

  • Cancer & Oncology11 studies
  • Liver & Kidney3 studies
  • Brain & Mental Health2 studies
  • Lungs & Breathing1 studies
  • Immune & Skin1 studies

Every listing shows the study phase, the recruiting site and its distance from Overland Park, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Overland Park

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Overland Park participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Are clinical trials in Overland Park safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Overland Park, KS?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
What is the difference between a research center and a hospital study in Overland Park?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Overland Park?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Overland Park.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Overland Park typically complete one or two studies per year.

Paid clinical trials near Overland Park

Other metros within reach

Olathe, KS1,039 Kansas City, KS1,043 Kansas City, MO1,031 Topeka, KS111 Springfield, MO147 Columbia, MO251 Omaha, NE593 Lincoln, NE159

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Overland Park Bladder Issues Due To Spinal Cord Injury in Overland Park All conditions

More of KS

Kansas City1,043 Olathe1,039 Wichita160 Topeka111

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts